Richard Millman is a Respiratory physician affiliated with Brown University. OpenAlex indexes 147 publications with 10,960 citations (h-index 54); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
375 Wampanoag Trl
Riverside, RI 029152232
Telephone
401-649-4070Provider last certified this registry record 5 Mar 2026.
Clinical trials
- Sodium Channel Splicing in Obstructive Sleep Apnea (SOCS-OSA)
Sponsor: Rhode Island Hospital
- Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Sponsor: Temple University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Inspire Medical Systems, Inc.Program year20241 payment
- JAZZ PHARMACEUTICALS INC.Program year20241 payment
- JAZZ PHARMACEUTICALS INC.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
76.7%Benzodiazepine12.7%Lorazepam37%Temazepam35%Alprazolam17%Clonazepam12%Part D<11 patientsgamma-Aminobutyric Acid A Receptor Positive Modulator12.4%Zolpidem Tartrate84%Zolpidem Tartrate Er16%Part D<11 patients+ 13 more classes in this area
Respiratory
19.2%beta2-Adrenergic Agonist7.3%Albuterol Sulfate Hfa81%Ventolin Hfa19%Part D<11 patientsCorticosteroid6.1%Breo Ellipta49%Budesonide-Formoterol Fumarate26%Fluticasone Propionate26%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
2.7%Corticosteroid2.7%Prednisone100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effects of Weight Loss on Obstructive Sleep Apnea Severity. Ten-Year Results of the Sleep AHEAD Study
American Journal of Respiratory and Critical Care Medicine
2020
Similar KOLs
Other experts from the same institution or the same specialty.
James Klinger, MD
Brown University
Thomas Dipetrillo, MD
Brown University
Sharon Rounds, MD
Brown University
William Corrao, MD
Brown University
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”